RX-10045

DRUG4 trials

Sponsors

Resolvyx Pharmaceuticals, Inc, C.T. Development America, Inc., A.T. Resolve SARL

Conditions

Allergic ConjunctivitisCataractDry Eye SyndromeInflammationPain

Phase 2

Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye

CompletedNCT00799552

Resolvyx Pharmaceuticals, IncDry Eye Syndrome

Start: 2008-11-30End: 2009-06-30Updated: 2010-09-24

Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis

CompletedNCT01639846

C.T. Development America, Inc.Allergic Conjunctivitis

Start: 2012-07-31End: 2012-08-31Updated: 2013-02-08

A Study of RX-10045 in the Treatment of Dry Eye Disease

CompletedNCT01675570

C.T. Development America, Inc.Dry Eye Syndrome

Start: 2012-08-31End: 2012-11-30Updated: 2013-02-08

Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery

CompletedNCT02329743

A.T. Resolve SARLCataract, Inflammation, Pain

Start: 2014-12-31End: 2015-09-30Updated: 2019-02-20